Foundation and Clinical About the Expression of PD-1 in Peripheral Blood T Lymphocytes

Summary

Providing more theoretical basis for the prediction of the efficacy of advanced NSCLC and helping select better advantaged population of NSCLC immunotherapy to maximize the benefits of patients By exploring the relationship between the changes of PD-1 expression in peripheral blood T lymphocytes and the clinical efficacy before and after the use of PD-1 / PD-L1 inhibitors.

Timeline

Start

2021-12-21

Primary completion

2023-03-01

Completion

2023-03-01

Drugs

Indications